Jamal Temsamani

Horse Hospital — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

31h-index5.2kcitations89works1.12yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA Interference and Gene Delivery(35), DNA and Nucleic Acid Chemistry(25), Advanced biosensing and bioanalysis techniques(24), Drug Transport and Resistance Mechanisms(12), Nanoparticle-Based Drug Delivery(11)

Publications89 total

DDDR-75. LDLR-Mediated Tumor Targeting Using a203Pb-Labeled Peptide: A Novel Strategy for Glioblastoma Imaging
Neuro-Oncology·2025Open Access
CTNI-76. UNLOCKING THE POWER OF LDL- RECEPTORS IN GLIOBLASTOMA
Neuro-Oncology·2025Open Access
Next-generation radiolabeled 203Pb-LDLR targeting peptides for imaging of pancreatic adenocarcinoma
Nuclear Medicine and Biology·2025
Novel single-domain antibodies targeting a unique transferrin receptor 1 epitope for cross-species delivery of drugs in the central nervous system
Journal of Controlled Release·2025Open Access
Novel VHH targeting a unique TfR1 epitope for efficient cross-species delivery of drugs in the CNS
2025Open Access
A peptide-neurotensin conjugate that crosses the blood-brain barrier induces pharmacological hypothermia associated with anticonvulsant, neuroprotective, and anti-inflammatory properties following status epilepticus in mice
eLife·2025Open Access
Author response: A peptide-neurotensin conjugate that crosses the blood-brain barrier induces pharmacological hypothermia associated with anticonvulsant, neuroprotective, and anti-inflammatory properties following status epilepticus in mice
2025Open Access
A peptide-neurotensin conjugate that crosses the blood-brain barrier induces pharmacological hypothermia associated with anticonvulsant, neuroprotective and anti-inflammatory properties following status epilepticus in mice
2024· 1 citedOpen Access
Author response: A peptide-neurotensin conjugate that crosses the blood-brain barrier induces pharmacological hypothermia associated with anticonvulsant, neuroprotective and anti-inflammatory properties following status epilepticus in mice
2024Open Access
A peptide-neurotensin conjugate that crosses the blood-brain barrier induces pharmacological hypothermia associated with anticonvulsant, neuroprotective and anti-inflammatory properties following status epilepticus in mice
2024Open Access
Author response: A peptide-neurotensin conjugate that crosses the blood-brain barrier induces pharmacological hypothermia associated with anticonvulsant, neuroprotective and anti-inflammatory properties following status epilepticus in mice
2024Open Access
A peptide-neurotensin conjugate that crosses the blood-brain barrier induces pharmacological hypothermia associated with anticonvulsant, neuroprotective, and anti-inflammatory properties following status epilepticus in mice
eLife·2024· 7 citedOpen Access
A peptide-neurotensin conjugate that crosses the blood-brain barrier induces pharmacological hypothermia associated with anticonvulsant, neuroprotective and anti-inflammatory properties following status epilepticus in mice
2024Open Access
A peptide-neurotensin conjugate that crosses the blood-brain barrier induces pharmacological hypothermia associated with anticonvulsant, neuroprotective and anti-inflammatory properties following status epilepticus in mice
2024· 1 citedOpen Access
LDLR-Mediated Targeting and Productive Uptake of siRNA-Peptide Ligand Conjugates In Vitro and In Vivo
Pharmaceutics·2024· 8 citedOpen Access
LDLR-mediated targeting and productive uptake of siRNA-peptide ligand conjugates <i>in vitro</i> and <i>in vivo</i>
2023Open Access
Abstract LB066: Targeting low density lipoprotein receptors in the pancreatic adenocarcinoma
Cancer Research·2022· 1 cited
Targeting LDLR-overexpressing glioblastoma and pancreatic ductal adenocarcinoma
Nuclear Medicine and Biology·2022
Abstract P099: Radionuclide imaging of low-density-lipoprotein receptor (LDLR)-overexpressing glioblastoma: A preclinical study of Gallium-68 RMX-VH
Molecular Cancer Therapeutics·2021
LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma
Communications Biology·2021· 18 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Sudhir Agrawal(19), Christophe Rousselle(9), Philippe Clair(8), Jean‐Michel Scherrmann(8), Anthony R. Rees(6), Guillaume Drin(5), Michel Kaczorek(5), Qiuyan Zhao(5), Jin Tang(4), Jean‐Michel Scherrmann(4), Pascaline Lécorché(4), Pascaline Lécorché(4), Michael Kubert(4), Jeanne-Marie Lefauconnier(3), Patricia L. Iadarola(3), Salvatore Cisternino(3), Karine Varini(3), Guillaume Jacquot(3), Philippe Guinot(3), Emmanuelle Blanc(2)